Press release
RNA Based Therapeutic Market Trend 2023: Anticipated Growth to Reach $25.12 Billion by 2030 | 17.6% CAGR
RNA Based Therapeutic Market
Key Takeaways:
Market Growth: The RNA-based therapeutic market has witnessed substantial growth and is expected to continue expanding in the coming years. This growth can be attributed to increasing investment in research and development, technological advancements, and a growing understanding of RNA-based therapeutics.
mRNA Therapeutics: Messenger RNA (mRNA) therapeutics have gained significant attention and have emerged as a promising approach in the field. mRNA vaccines, such as the ones developed for COVID-19, have demonstrated their efficacy and have paved the way for further exploration of mRNA-based treatments for various diseases, including cancer, infectious diseases, and genetic disorders.
RNA Interference (RNAi) Therapeutics: RNA interference is a mechanism that regulates gene expression. RNAi therapeutics utilize small interfering RNA (siRNA) molecules to silence specific genes involved in disease processes. RNAi-based drugs have shown potential in treating various diseases, particularly in the field of rare genetic disorders and liver-related diseases.
Therapeutic Applications: RNA-based therapeutics hold promise for a wide range of diseases. They have shown potential in treating genetic disorders, cancer, infectious diseases, cardiovascular diseases, neurodegenerative diseases, and autoimmune disorders. The versatility of RNA-based therapies allows for targeted and personalized treatment approaches.
Market Players: Several pharmaceutical and biotechnology companies are actively involved in the development and commercialization of RNA-based therapeutics. Companies like Moderna, BioNTech, Alnylam Pharmaceuticals, and Arrowhead Pharmaceuticals have made significant advancements in this field and have gained attention for their innovative approaches.
Download Sample Report- https://www.alliedmarketresearch.com/request-sample/546
Market Drivers:
Growing Demand for Targeted and Personalized Medicine: RNA-based therapeutics offer the potential for targeted and personalized treatments. They can be designed to specifically target disease-causing genes or proteins, providing a more precise approach compared to traditional therapies. The increasing demand for personalized medicine and targeted therapies is driving the growth of the RNA-based therapeutic market.
Advancements in RNA Delivery Technologies: Efficient delivery of RNA molecules to target cells or tissues is crucial for the success of RNA-based therapeutics. Recent advancements in delivery technologies, such as lipid nanoparticle formulations and viral vectors, have improved the efficiency and specificity of delivering RNA molecules to the desired sites. These advancements have expanded the potential applications of RNA-based therapies and have contributed to market growth.
Market Segmentation:
Therapeutic Modality:
mRNA Therapeutics: This segment includes mRNA-based therapies that utilize synthetic mRNA molecules to encode proteins of interest or trigger specific cellular responses.
RNA Interference (RNAi) Therapeutics: This segment comprises therapies based on RNA interference, which involve the use of small interfering RNA (siRNA) molecules to silence or modulate the expression of disease-causing genes.
Antisense Oligonucleotides (ASOs): ASOs are short synthetic DNA or RNA molecules that bind to specific RNA targets, influencing gene expression or protein production. This segment includes therapies based on ASOs.
Application:
Oncology: This segment includes RNA-based therapeutics used in the treatment of various types of cancers.
Infectious Diseases: RNA-based therapies targeting viral or bacterial infections fall under this segment.
Genetic Disorders: This segment encompasses therapies targeting inherited or genetic disorders caused by mutations or abnormalities in specific genes.
Cardiovascular Diseases: RNA-based therapeutics aimed at treating cardiovascular diseases, such as heart failure or genetic cardiac disorders, belong to this segment.
Neurodegenerative Diseases: Therapies targeting neurodegenerative disorders, such as Alzheimer's, Parkinson's, or Huntington's disease, fall into this segment.
Rare Diseases: This segment includes RNA-based therapies developed for rare diseases that have a low prevalence in the population.
Other Applications: RNA-based therapeutics targeting autoimmune disorders, respiratory diseases, and other therapeutic areas can be categorized under this segment.
End User:
Hospitals and Clinics: RNA-based therapeutics administered in healthcare facilities, including hospitals and clinics, are included in this segment.
Research Institutes: This segment comprises RNA-based therapies utilized in research settings or academic institutions for preclinical or clinical studies.
Pharmaceutical and Biotechnology Companies: RNA-based therapies developed and commercialized by pharmaceutical and biotech companies fall into this segment.
Request for Customization -
https://www.alliedmarketresearch.com/request-for-customization/546
Regional Growth Dynamics:
By region, the market across North America dominated in 2020, garnering more than two-fifths the global RNA based therapeutics market. High expenditure on R&D, presence of major players & their product availability, and well-established healthcare infrastructure in the region propel the market growth. Simultaneously, the Asia-Pacific region is also expected to cite the fastest CAGR of 18.9% throughout the forecast period. This is attributed to improvements in R&D facilities, available disposable income, and rapidly developing economic conditions.
Key players in the industry-
Silence Therapeutics plc.
Arbutus Biopharma Corporation
Ionis Pharmaceuticals
Sarepta Therapeutics
Alnylam Pharmaceuticals, Inc.
Benitec Biopharma Inc.
Genzyme (Sanofi), Arrowhead Pharmaceuticals
Biogen, Inc.
Gradalis, Inc.
Related Reports :
Body Composition Analyzers Market: https://www.alliedmarketresearch.com/body-composition-analyzers-market
Syringes Market: https://www.alliedmarketresearch.com/syringes-market-A07514
Medical Aesthetic Devices Market: https://www.alliedmarketresearch.com/medical-aesthetics-market
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com
Allied Market Research Blog: https://blog.alliedmarketresearch.com
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release RNA Based Therapeutic Market Trend 2023: Anticipated Growth to Reach $25.12 Billion by 2030 | 17.6% CAGR here
News-ID: 3133893 • Views: …
More Releases from Allied Market Research
Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
The global urinary drainage bags market is experiencing robust growth, with its market size valued at $1.4billion in 2021 and projected to reach $2billion by 2031. This expansion represents a compound annual growth rate (CAGR) of 3.8% from 2021 to 2031, highlighting the increasing demand for these essential medical devices.
Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A17529
What Are Urinary Drainage Bags?
Urinary drainage bags are specialized medical devices designed to collect…
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
The global cream powder industry was estimated at $4.8 billion in 2021 and is expected to hit $8.9 billion by 2031, registering a CAGR of 6.4% from 2022 to 2031.
The cream powder market is experiencing growth due to various factors, including the increasing popularity of bakeries and HoReCa (hotels, restaurants, and cafes) and rising consumer demand for natural products. The dairy-based segment is a significant contributor to the market's growth…
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Bil …
The global micro drone industry generated $6.71 billion in 2020, and is expected to reach $28.91 billion in 2030, witnessing a CAGR of 17.2% from 2021 to 2030. The report provides an extensive analysis of changing market dynamics, top segments, top investment pockets, regional landscape, value chain, and competitive scenario.
Increased operational efficiency and rise in demand for improved surveillance drive the growth of the global micro drone market. However, strict…
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of …
The global microwaveable foods industry was accounted for $120.45 billion in 2020, and is expected to reach $230.93 billion by 2031, growing at a CAGR of 5.6% from 2022 to 2031.
Rise in popularity of fast-food restaurants and large population base coupled with increase in number of quick-service restaurants drive the global microwaveable foods market. However, lack of awareness about microwavable foods hinders the market growth. On the contrary, rise in…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
